PMV Pharmaceuticals Inc

NASDAQ:PMVP   3:59:52 PM EDT
29.30
-0.32 (-1.08%)
Earnings Announcements

PMV Pharmaceuticals Ended Q2 With $339 Mln In Cash, Cash Equivalents, And Marketable Securities

Published: 08/13/2021 10:38 GMT
PMV Pharmaceuticals Inc (PMVP) - Pmv Pharmaceuticals - Ended Q2 With $339.0 Million in Cash, Cash Equivalents, and Marketable Securities.
Pmv Pharmaceuticals Qtrly Loss per Share $0.29.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.